Fisheries Bycatch Yields Antimicrobial Peptides Active Against Drug-Resistant Bacteria
Proteomic analysis of fisheries bycatch species identified novel antimicrobial peptides with activity against drug-resistant bacteria, transforming ecological waste into therapeutic leads.
Quick Facts
What This Study Found
Proteomic analysis of fisheries bycatch identified novel antimicrobial peptides with broad-spectrum activity including against drug-resistant bacterial strains.
Key Numbers
How They Did This
Proteomic characterization of bycatch species, peptide identification and purification, antimicrobial activity testing against standard and drug-resistant strains.
Why This Research Matters
Converting fisheries waste into antimicrobial peptide leads addresses both ecological waste and the antibiotic resistance crisis simultaneously.
The Bigger Picture
Marine organisms are among the richest natural sources of bioactive peptides. Using bycatch for peptide discovery aligns drug development with sustainability goals.
What This Study Doesn't Tell Us
In vitro activity only. Specific peptide sequences and potencies need full characterization. Scalability of bycatch-based peptide production uncertain.
Questions This Raises
- ?Which bycatch species yield the most potent AMPs?
- ?Can these peptides be produced recombinantly at scale?
- ?How do marine-derived AMPs compare to terrestrial sources?
Trust & Context
- Key Stat:
- Waste to medicine Fisheries bycatch, normally discarded, yields antimicrobial peptides effective against drug-resistant bacteria
- Evidence Grade:
- Discovery-stage proteomic study with initial antimicrobial validation. Novel concept needing further peptide characterization.
- Study Age:
- Published in 2025.
- Original Title:
- Proteomic and Functional Characterization of Antimicrobial Peptides Derived from Fisheries Bycatch via Enzymatic Hydrolysis.
- Published In:
- Marine drugs, 24(1) (2026)
- Authors:
- Galendi, Vicky Balesteros S Blumen, Coelho, Guilherme Rabelo(2), Murback, Letícia, Valenti, Wagner C, Camargo, Tavani Rocha, Franzolin, Marcia Regina, Pimenta, Daniel Carvalho, Ferreira, Rui Seabra
- Database ID:
- RPEP-15181
Evidence Hierarchy
Frequently Asked Questions
What is fisheries bycatch?
Bycatch is marine life caught unintentionally during fishing operations. Rather than being wasted, these organisms can be a source of valuable bioactive molecules including antimicrobial peptides.
Can fish waste really produce antibiotics?
Yes. Marine organisms produce antimicrobial peptides as part of their immune defense. This study shows that even bycatch species contain novel peptides effective against drug-resistant bacteria.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15181APA
Galendi, Vicky Balesteros S Blumen; Coelho, Guilherme Rabelo; Murback, Letícia; Valenti, Wagner C; Camargo, Tavani Rocha; Franzolin, Marcia Regina; Pimenta, Daniel Carvalho; Ferreira, Rui Seabra. (2026). Proteomic and Functional Characterization of Antimicrobial Peptides Derived from Fisheries Bycatch via Enzymatic Hydrolysis.. Marine drugs, 24(1). https://doi.org/10.3390/md24010036
MLA
Galendi, Vicky Balesteros S Blumen, et al. "Proteomic and Functional Characterization of Antimicrobial Peptides Derived from Fisheries Bycatch via Enzymatic Hydrolysis.." Marine drugs, 2026. https://doi.org/10.3390/md24010036
RethinkPeptides
RethinkPeptides Research Database. "Proteomic and Functional Characterization of Antimicrobial P..." RPEP-15181. Retrieved from https://rethinkpeptides.com/research/galendi-2026-proteomic-and-functional-characterization
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.